Institute for Respiratory Health | Perth , Australia

Research site
QEII Medical Centre, Level 2, 6 Verdun Street, Perth, Western Australia, Australia
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


1 of 2
Status: Active
Trial type: Interventional
Funder type: Industry

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

A double-blind, active-controlled, multiple-ascending dose, safety study of aerosolized RSP-1502 in subjects with cystic fibrosis Pseudomonas aerugin...

Cystic Fibrosis Lung
Pseudomonas Aeruginosa
Drug: RSP-1502
Drug: Tobramycin inhalation solution

Trial conditions

Cardiovascular Diseases (1 trial)
Chronic Obstructive Pulm... (1 trial)
Communicable Diseases (1 trial)
Cystic Fibrosis (1 trial)
Fibrosis (1 trial)
Infections (1 trial)
Lung Diseases (1 trial)
Obstructive Lung Diseases (1 trial)
Pseudomonas Infections (1 trial)
Pulmonary Fibrosis (1 trial)

And 2 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems